399 related articles for article (PubMed ID: 20063108)
21. Heme-nitrosyls: electronic structure implications for function in biology.
Hunt AP; Lehnert N
Acc Chem Res; 2015 Jul; 48(7):2117-25. PubMed ID: 26114618
[TBL] [Abstract][Full Text] [Related]
22. Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase.
Underbakke ES; Iavarone AT; Marletta MA
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6777-82. PubMed ID: 23572573
[TBL] [Abstract][Full Text] [Related]
23. Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.
Rothkegel C; Schmidt PM; Atkins DJ; Hoffmann LS; Schmidt HH; Schröder H; Stasch JP
Mol Pharmacol; 2007 Nov; 72(5):1181-90. PubMed ID: 17715400
[TBL] [Abstract][Full Text] [Related]
24. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase.
Newton M; Niewczas I; Clark J; Bellamy TC
Anal Biochem; 2010 Jul; 402(2):129-36. PubMed ID: 20371357
[TBL] [Abstract][Full Text] [Related]
25. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
26. Regulation of nitric oxide and soluble guanylyl cyclase.
Krumenacker JS; Hanafy KA; Murad F
Brain Res Bull; 2004 Feb; 62(6):505-15. PubMed ID: 15036565
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of recombinant human soluble guanylate cyclase produced from baculovirus-infected insect cells.
Emmons TL; Mathis KJ; Shuck ME; Reitz BA; Curran DF; Walker MC; Leone JW; Day JE; Bienkowski MJ; Fischer HD; Tomasselli AG
Protein Expr Purif; 2009 Jun; 65(2):133-9. PubMed ID: 19189860
[TBL] [Abstract][Full Text] [Related]
28. Characterization of two different five-coordinate soluble guanylate cyclase ferrous-nitrosyl complexes.
Derbyshire ER; Gunn A; Ibrahim M; Spiro TG; Britt RD; Marletta MA
Biochemistry; 2008 Mar; 47(12):3892-9. PubMed ID: 18302323
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
[TBL] [Abstract][Full Text] [Related]
30. Quaternary structure controls ligand dynamics in soluble guanylate cyclase.
Yoo BK; Lamarre I; Martin JL; Negrerie M
J Biol Chem; 2012 Feb; 287(9):6851-9. PubMed ID: 22223482
[TBL] [Abstract][Full Text] [Related]
31. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex.
Dai Y; Stuehr DJ
Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790
[TBL] [Abstract][Full Text] [Related]
32. The titerless infected-cells preservation and scale-up (TIPS) method for large-scale production of NO-sensitive human soluble guanylate cyclase (sGC) from insect cells infected with recombinant baculovirus.
Wasilko DJ; Lee SE; Stutzman-Engwall KJ; Reitz BA; Emmons TL; Mathis KJ; Bienkowski MJ; Tomasselli AG; Fischer HD
Protein Expr Purif; 2009 Jun; 65(2):122-32. PubMed ID: 19174191
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the Alpha subunit PAS domain from soluble guanylyl cyclase.
Purohit R; Weichsel A; Montfort WR
Protein Sci; 2013 Oct; 22(10):1439-44. PubMed ID: 23934793
[TBL] [Abstract][Full Text] [Related]
34. Mapping of heme-binding domains in soluble guanylyl cyclase beta1 subunit.
Namiki S; Hirose K; Iino M
Biochem Biophys Res Commun; 2001 Nov; 288(4):798-804. PubMed ID: 11688978
[TBL] [Abstract][Full Text] [Related]
35. Allostery in recombinant soluble guanylyl cyclase from Manduca sexta.
Hu X; Murata LB; Weichsel A; Brailey JL; Roberts SA; Nighorn A; Montfort WR
J Biol Chem; 2008 Jul; 283(30):20968-77. PubMed ID: 18515359
[TBL] [Abstract][Full Text] [Related]
36. Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP.
Cary SP; Winger JA; Marletta MA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13064-9. PubMed ID: 16131543
[TBL] [Abstract][Full Text] [Related]
37. Human soluble guanylate cyclase: functional expression, purification and structural characterization.
Kosarikov DN; Young P; Uversky VN; Gerber NC
Arch Biochem Biophys; 2001 Apr; 388(2):185-97. PubMed ID: 11368154
[TBL] [Abstract][Full Text] [Related]
38. Biochemistry of soluble guanylate cyclase.
Derbyshire ER; Marletta MA
Handb Exp Pharmacol; 2009; (191):17-31. PubMed ID: 19089323
[TBL] [Abstract][Full Text] [Related]
39. On the activation of soluble guanylyl cyclase by nitric oxide.
Bellamy TC; Wood J; Garthwaite J
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):507-10. PubMed ID: 11752394
[TBL] [Abstract][Full Text] [Related]
40. The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change.
Pan J; Zhang X; Yuan H; Xu Q; Zhang H; Zhou Y; Huang ZX; Tan X
Biochim Biophys Acta; 2016 May; 1864(5):488-500. PubMed ID: 26876536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
